Persistence of bactericidal antibodies following booster vaccination with 4CMenB at 12, 18, or 24 months and immunogenicity of a fifth dose administered at 4 years of age - a phase 3 extension to a randomised controlled trial
Persistence of bactericidal antibodies following booster vaccination with 4CMenB at 12, 18, or 24 months and immunogenicity of a fifth dose administered at 4 years of age - a phase 3 extension to a randomised controlled trial
395-402
Iro, Mildred
8a5c81c4-0746-4f19-b1fc-7889d20e02eb
Snape, Matthew D.
ea21c8b9-e907-4914-9052-ae9eb56f54d7
Voysey, Merryn
fd9bd72b-7aaf-4390-a27f-bd8a6e6d92ae
Jawad, Sena
af2586a2-4d29-47b4-a604-0d138d0e87e9
Finn, Adam
59ac74fa-55a6-448d-9e19-9dd2f4654d4b
Heath, Paul T.
b9b6e0e4-6bd0-4c16-b9f6-607b00137fe4
Bona, Gianni
c98aa520-0aee-43d2-b3e1-fa84b844cf69
Esposito, Susanna
b3381199-6003-4f0e-8e81-b0d11e923f5d
Diez-Domingo, Javier
5aa1bf0e-bb78-44cc-855e-c8f63955c999
Prymula, Roman
284e7e09-e94e-4435-9029-db7daaf2b427
Odueyungbo, Adefowope
a90d7cae-f663-42ba-a0c5-35b4f55454ff
Toneatto, Daniela
bf55b80e-bf0e-40ff-96b7-2bc9aacbdda9
Dull, Peter
696fc5c3-5bda-49ff-b8d6-e875ef0114be
Pollard, Andrew J.
f54083f3-c730-4ecb-937e-6fb11fdd6a21
European Men B Vaccine Study Group,
11f3e811-16e7-4642-b04a-2815b88dd920
5 January 2017
Iro, Mildred
8a5c81c4-0746-4f19-b1fc-7889d20e02eb
Snape, Matthew D.
ea21c8b9-e907-4914-9052-ae9eb56f54d7
Voysey, Merryn
fd9bd72b-7aaf-4390-a27f-bd8a6e6d92ae
Jawad, Sena
af2586a2-4d29-47b4-a604-0d138d0e87e9
Finn, Adam
59ac74fa-55a6-448d-9e19-9dd2f4654d4b
Heath, Paul T.
b9b6e0e4-6bd0-4c16-b9f6-607b00137fe4
Bona, Gianni
c98aa520-0aee-43d2-b3e1-fa84b844cf69
Esposito, Susanna
b3381199-6003-4f0e-8e81-b0d11e923f5d
Diez-Domingo, Javier
5aa1bf0e-bb78-44cc-855e-c8f63955c999
Prymula, Roman
284e7e09-e94e-4435-9029-db7daaf2b427
Odueyungbo, Adefowope
a90d7cae-f663-42ba-a0c5-35b4f55454ff
Toneatto, Daniela
bf55b80e-bf0e-40ff-96b7-2bc9aacbdda9
Dull, Peter
696fc5c3-5bda-49ff-b8d6-e875ef0114be
Pollard, Andrew J.
f54083f3-c730-4ecb-937e-6fb11fdd6a21
European Men B Vaccine Study Group,
11f3e811-16e7-4642-b04a-2815b88dd920
Iro, Mildred, Snape, Matthew D., Voysey, Merryn, Jawad, Sena, Finn, Adam, Heath, Paul T., Bona, Gianni, Esposito, Susanna, Diez-Domingo, Javier, Prymula, Roman, Odueyungbo, Adefowope, Toneatto, Daniela, Dull, Peter, Pollard, Andrew J. and European Men B Vaccine Study Group,
(2017)
Persistence of bactericidal antibodies following booster vaccination with 4CMenB at 12, 18, or 24 months and immunogenicity of a fifth dose administered at 4 years of age - a phase 3 extension to a randomised controlled trial.
Vaccine, 35 (2), .
(doi:10.1016/j.vaccine.2016.11.009).
This record has no associated files available for download.
More information
Accepted/In Press date: 3 November 2016
e-pub ahead of print date: 30 November 2016
Published date: 5 January 2017
Identifiers
Local EPrints ID: 424446
URI: http://eprints.soton.ac.uk/id/eprint/424446
ISSN: 0264-410X
PURE UUID: f5bd81bd-2ccf-4b66-9c4e-624c6cc39c58
Catalogue record
Date deposited: 05 Oct 2018 11:37
Last modified: 16 Mar 2024 04:36
Export record
Altmetrics
Contributors
Author:
Matthew D. Snape
Author:
Merryn Voysey
Author:
Sena Jawad
Author:
Adam Finn
Author:
Paul T. Heath
Author:
Gianni Bona
Author:
Susanna Esposito
Author:
Javier Diez-Domingo
Author:
Roman Prymula
Author:
Adefowope Odueyungbo
Author:
Daniela Toneatto
Author:
Peter Dull
Author:
Andrew J. Pollard
Author:
European Men B Vaccine Study Group
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics
